Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Bolt Biotherapeutics Ownership Summary


Bolt Biotherapeutics is owned by 28.68% institutional investors, 6.66% insiders, and 64.66% retail investors. Vivo capital is the largest institutional shareholder, holding 9.18% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics28.68%6.66%64.66%
SectorHealthcare Stocks 231.98%10.74%-142.72%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vivo capital176.06K9.18%$936.66K
Sofinnova investments137.72K7.18%$732.68K
Citadel advisors2.37M6.22%$1.78M
Pivotal bioventure partners investment advisor94.57K4.93%$503.13K
Tang capital management66.88K3.49%$355.80K
Nan fung group58.35K3.04%$310.41K
Renaissance55.02K2.87%$300.88K
Samsara biocapital48.83K2.55%$259.78K
Board of trustees of the leland stanford junior university35.98K1.88%$191.40K
Pfizer31.30K1.63%$171.18K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group58.35K0.52%$310.41K
Pivotal bioventure partners investment advisor94.57K0.29%$503.13K
Nano cap new millennium growth fund l p20.50K0.10%$112.09M
Vivo capital176.06K0.08%$936.66K
Pfizer31.30K0.07%$171.18K
Sofinnova investments137.72K0.04%$732.68K
Samsara biocapital48.83K0.03%$259.78K
Board of trustees of the leland stanford junior university35.98K0.02%$191.40K
Tang capital management66.88K0.01%$355.80K
Shay capital15.96K0.01%$84.90K

Top Buyers

HolderShares% AssetsChange
Renaissance55.02K0.00%26.40K
Nano cap new millennium growth fund l p20.50K0.10%20.50K
Shay capital15.96K0.01%15.96K
Blackrock267.07K-12.11K
Ubs group515.00-512.00

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.54M
Acuitas investments---630.51K
Adage capital partners gp---500.00K
Newtyn management---468.91K
Susquehanna group, llp---147.93K

New Positions

HolderShares% AssetsChangeValue
Nano cap new millennium growth fund l p20.50K0.10%20.50K$112.09M
Shay capital15.96K0.01%15.96K$84.90K
Citigroup256.00-256.00$1.40K

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Qube research-2.00
Salem investment counselors-2.00
Fmr-121.00
Wells fargo & company/mn-211.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202517-29.17%550,535-31.53%281.63%6-14.29%2-75.00%
Sep 30, 2025244.35%804,036-9.28%41784.60%7250.00%8-61.90%
Jun 30, 202524-14.29%889,879-95.14%240.64%2-80.00%22340.00%
Mar 31, 202528-24.32%18,325,858-1.84%472.01%10-41.18%5-
Dec 31, 20243719.35%18,670,034-0.60%482.02%1770.00%5-37.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv47.18K2.46%-1.03K
Vanguard US Total Market Shares ETF861.87K2.25%-1.00
Fidelity Extended Market Index7.20K0.38%270.00
Vanguard Institutional Extnd Mkt Idx Tr7.06K0.37%-
PGIM US Micro Cap Quant Equity5.78K0.30%-
Fidelity Total Market Index5.35K0.28%-
NT Ext Equity Mkt Idx Fd - L5.01K0.26%3.72K
Fidelity Enhanced Small Cap ETF90.25K0.24%1.69K
Spartan Extended Market Index Pool F3.13K0.16%-
Bridgeway Ultra-Small Company Market60.20K0.16%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2025Quinn William P. President, CEO and CFOBuy$575.88
Dec 05, 2025Nemec Sarah Senior VP, Finance and PAOBuy$575.88
Jun 06, 2025Nemec Sarah Senior VP, Finance and PAOBuy$686.50
Jun 06, 2025Quinn William P. President, CEO and CFOBuy$686.50
Dec 16, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.24K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q22-
2024 Q42-
2024 Q3--
2024 Q2--

BOLT Ownership FAQ


Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 28.68%, followed by 6.66% insiders and 64.66% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 381.47%, which Bolt Biotherapeutics falls below.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Vivo capital (176.06K shares, 9.18%), Sofinnova investments (137.72K shares, 7.18%), and Citadel advisors (2.37M shares, 6.22%). Together, they hold 22.58% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.52% of its assets in 58.35K Bolt Biotherapeutics shares, valued at 310.41K$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.46% of its total shares outstanding invested in 47.18K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools